This is a non-core endpoint: only basic statistics are computed.
Carcinoma in situ, thyroid and other endocrine glands
CD2_INSITU_THYROICD2_ENDOCRINE_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D09
- Name in latin
- Carcinoma in situ glandulae thyreoideae
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ, thyroid and other endocrine glands
based on the number of shared cases.
Similar with more cases:
- Carcinoma in situ, thyroid and other endocrine glands
- Carcinoma in situ of other and unspecified sites
- Carcinoma in situ of other and unspecified sites
- In situ neoplasms
- In situ neoplasms
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 11 | 9 | - |
| Unadjusted period prevalence (%) | 0.00 | 0.00 | - |
| Median age at first event (years) | 46.66 | 44.82 | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
11
76
+∞
1.48
8.5
3.9
17.9
14.8
pmol/l
4.82
11
67
0
17
0.00
0.44
0.0
1.8
—
433.6
—
0
10
11
92
+∞
0.44
9.5
4.8
0.7
1.9
mu/l
4.79
11
78
5
40
1.45
0.27
4.2
4.7
—
—
—
0
0
0
11
0.00
0.22
0.0
3.8
—
—
—
0
0
11
99
+∞
0.22
15.6
13.8
4.0
4.0
mmol/l
0.12
11
93
0
10
0.00
0.22
0.0
2.9
—
—
—
0
0
11
98
+∞
0.22
16.5
14.0
67.8
75.1
umol/l
0.72
11
98
11
97
+∞
0.22
15.5
14.0
140.7
139.7
mmol/l
1.00
11
92
0
9
0.00
0.00
0.0
2.8
—
—
—
0
0
11
102
+∞
0.00
6.5
8.9
24.7
23.4
u/l
0.13
11
94
5
47
1.12
0.00
1.4
2.2
59.0
81.9
nmol/l
—
5
39
0
7
0.00
0.00
0.0
3.0
—
1.2
—
0
7
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_THYROICD2_ENDOCRINE_EXALLC – Carcinoma in situ, thyroid and other endocrine glands
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).